
LMAT
USDLeMaitre Vascular Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$83.000
Haut
$89.010
Bas
$81.570
Volume
0.06M
Fondamentaux de l'Entreprise
Capitalisation Boursière
2.0B
Industrie
Medical Instruments & Supplies
Pays
United States
Statistiques de Trading
Volume Moyen
0.17M
Bourse
NGM
Devise
USD
Intervalle sur 52 Semaines
Rapport d'Analyse IA
Dernière mise à jour: 30 oct. 2025LMAT Analysis: LeMaitre Vascular Faces Key Inflection Point Ahead of Earnings
Price Action: Volatility and Support Testing
LeMaitre Vascular (LMAT) has experienced a rollercoaster ride over the past three months. The stock surged from $81 to $93.04 in early August (+15%) but later dropped to $84.66 in late September (-9%), only to stabilize near $88.55 as of October 30. Key patterns to note:
- Support Zone Alert: The stock hovers near $89.16, a critical support level. Recent lows on October 29 ($88.33) and October 30 ($87.82) suggest sellers are testing this level.
- Volume Contrasts: Surge days (August 6: +18%, volume 428,600) contrast sharply with the 509,700 volume crash on August 26 (-5%), indicating emotional retail trader involvement.
- Technical Tug-of-War: Mixed signals - the MACD "death cross" warns of bearish momentum, while the OBV spike on October 30 shows sudden buying pressure.
Sentiment: Analysts Push Against Market Skepticism
- Positive Catalyst: Barrington Research reiterated its $95 price target on October 15, implying 7.2% upside from current levels. 8 analysts collectively project a $104.62 average target (+17.9% potential).
- Earnings Countdown: The company’s Q3 results (November 6) create a natural inflection point. Historical volatility around reporting dates could amplify moves post-announcement.
- Market Disconnect: Despite the analyst optimism, the stock underperforms its 52-week high ($109.58) by 19% and trades below its P/E ratio of 40.81, which the model flags as "neutral" (not overvalued nor undervalued).
Predictive Outlook: AI Detects Short-Term Momentum
AI models project a cautious upside over 3 days:
- Day 1: +0.2% (flat move, low confidence)
- Day 2: +2.6% (strongest signal)
- Day 3: +2.3% (sustained momentum) Combined with the $91.57 AI target, this suggests potential rebound energy if support at $89.16 holds. However, the technical DMI (-DI 12.5 vs. +DI 8.8) warns of unresolved bearish pressure.
Strategic Guidance: Play the Range, Watch Debt Shadows
Entry Opportunities: If volume surges above 150,000, consider nibbling at shares near the support cluster ($89.09-$90.30). The technical setup favors a bounce, but the high debt-to-equity ratio (51.
Actualités Connexes
Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $95 Price Target
Barrington Research analyst Michael Petusky maintains LeMaitre Vascular with a Outperform and maintains $95 price target.
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market
Prédiction IABeta
Recommandation IA
Mis à jour le: 10 nov. 2025, 10:37
63.1% Confiance
Risque et Trading
Point d'Entrée
$86.47
Prise de Bénéfices
$88.43
Stop Loss
$78.02
Facteurs Clés
Actions Connexes
LYEL
Lyell Immunopharma Inc.
LSBPW
LakeShore Biopharma Co. Ltd Warrants
FORL
Four Leaf Acquisition Corporation
TDS
Telephone and Data Systems Inc. Common Shares
MIY
Blackrock MuniYield Michigan Quality Fund Inc.
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.